Evidence map›Paper›PMID 31215222›Full record

ArticleAnnals of Saudi medicine

Prevalence and 20-year epidemiological trends of glomerular diseases in the adult Saudi population: a multicenter study.

Talal AlFaadhel, Abdulkareem Alsuwaida, Khaled Alsaad, Lamees Almezaini, Noura Ahmed, Mahmoud Yassin AlHamad, Ammar Bakheet, Junaid Wadera, Ghadeer Mokhtar, Feras Alsuwaida and 9 more

Open access · diamondAbstract readMulticenter Study
In one paragraph

Article in Annals of Saudi medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Renal biopsy reports in nephritic syndrome: Update.World journal of nephrology · 2022
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Talal AlFaadhelFrom Department of Medicine, College of Medicine King Saud University, Riyadh, Saudi Arabia.
Abdulkareem AlsuwaidaFrom Department of Medicine, College of Medicine King Saud University, Riyadh, Saudi Arabia.
Khaled AlsaadFrom Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Lamees AlmezainiFrom Department of Medicine, College of Medicine King Saud University, Riyadh, Saudi Arabia.
Noura AhmedFrom Department of Medicine, College of Medicine King Saud University, Riyadh, Saudi Arabia.
Mahmoud Yassin AlHamadFrom Department of Medicine, College of Medicine King Saud University, Riyadh, Saudi Arabia.
Ammar BakheetFrom Department of Medicine, College of Medicine King Saud University, Riyadh, Saudi Arabia.
Junaid WaderaFrom Department of Medicine, College of Medicine King Saud University, Riyadh, Saudi Arabia.
Ghadeer MokhtarFrom Department of Pathology and Laboratory Medicine, King Abdulaziz University Hosppital, Jeddah, Saudi Arabia.
Feras AlsuwaidaFrom Department of Medicine, College of Medicine King Saud University, Riyadh, Saudi Arabia.
Rehan SiddiquiFrom Department of Nephrology, Security Forces Hospital, Riyadh, Saudi Arabia.
Mohamed KechridFrom Department of Nephrology, Security Forces Hospital, Riyadh, Saudi Arabia.
Ashraf AbdelrehmanFrom Department of Nephrology, Security Forces Hospital, Riyadh, Saudi Arabia.
Sufia HusainFrom Department of Pathology and Laboratory Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Hala KfouryFrom Department of Pathology and Laboratory Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Abdulrahaman AlabdulsalamFrom Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Majed AlanaziFrom Department of Internal Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Noura Al OudahFrom Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Hanadi AlHozaliFrom Deaprtment of Internal Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
King Saud University · SAKing Abdulaziz Medical City · SASecurity Forces Hospital · SAKing Abdulaziz University · SAKing Faisal Specialist Hospital & Research Centre · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent international reports have shown significant changes in the incidence of different glomerular diseases.

objectiveExamine temporal and demographic trends of biopsy-diagnosed glomerular diseases in the adult population of Saudi Arabia over the last two decades.

designMedical record review. SETTINGS: Four tertiary medical centers in Saudi Arabia. PATIENTS AND

methodsWe identified all patients that underwent native kidney biopsy between 1998 and 2017.

main outcome measuresThe frequency and the disease trends in four biopsy eras (1998-2002, 2003-2007, 2008-2011, and 2012-2017) for different glomerular diseases. SAMPLE SIZE AND CHARACTERISTICS: 1070 patients, 18-65 years of age; 54.1% female.

resultsOf 1760 patients who underwent native kidney biopsies, 1070 met inclusion criteria. Focal segmental glomerulosclerosis was the most common biopsy-diagnosed disease, with comparable frequencies over the four eras (23.6%, 19.8%, 24.1%, and 17.1, respectively [ P value for trend=.07]). The frequency of immunoglobulin A nephropathy increased progressively. The incidence of membranoproliferative glomerulonephritis declined significantly. Among the secondary types of glomerular diseases, systemic lupus erythematosus-associated lupus nephritis was the most common, followed by diabetic nephropathy. The prevalence of diabetic nephropathy increased from 1.4% in the first era to 10.2% in the last one.

conclusionsTrends in biopsy-diagnosed glomerular disease have changed. While focal segmental glomerulosclerosis remains the most common glomerular disease, there has been a significant rise in the prevalence of immunoglobulin A nephropathy and diabetic nephropathy. In contrast, membranoproliferative glomerulonephritis has declined. LIMITATIONS: Retrospective methodologies are vulnerable to lost data. CONFLICT OF INTEREST: None.

Indexed as

AdolescentAdultAgedBiopsyDiabetic NephropathiesFemaleGlomerulonephritis, IGAGlomerulosclerosis, Focal SegmentalHumansIncidenceKidney DiseasesLupus NephritisMaleMiddle AgedPrevalenceRetrospective Studies

Identifiers

PMID31215222
PMCPMC6832335
OpenAlexW2947661632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.